Appointment of non-executive director

RNS Number : 0031Y

Gooch & Housego PLC

23 February 2012

 



For immediate release

23 February 2012

Gooch & Housego PLC

Appointment of non-executive director

Gooch & Housego PLC, the specialist manufacturer of optical components and systems, today announces that Mr Mark Webster and Dr Peter Bordui were appointed to the Board as non-executive Directors at the board meeting held on 22^nd February 2012.

Mark Webster, 50, has over twenty five years' experience in the healthcare industry in senior leadership roles for Abbott Laboratories, Shire Pharmaceuticals, Bayer Healthcare and ProStrakan. He is currently a director and Chief Executive Officer of Bio Products Laboratory Ltd. Previous roles include: -

·     Non-executive director of Abcam plc

·     Head of Global Strategic Marketing and North America for ProStrakan

·     Senior Vice President and Head of Global Strategic Marketing and Licensing/ Acquisitions for Bayer Healthcare and a member of Bayer's Pharmaceutical Management Committee

·     Head of Global Strategic Marketing and Licensing/Acquisitions for Shire Pharmaceuticals and a member of the Executive Committee

·     Head of the Pharmaceutical and Hospital Divisions in the UK, the Hospital Division in Canada and latterly as Vice President, Anti-Virals, US Pharmaceutical Division for Abbott Laboratories

Mr Webster holds an honours degree in Chemistry from the University of Durham.

Peter Bordui, 51, has twenty-five years' experience in the photonics industry in senior leadership roles with Bookham, New Focus, JDSU and Crystal Technology (at the time a subsidiary of Siemens), and has held a number of additional non-executive director roles. He is currently a non-executive director of M-Squared Lasers Ltd., BeamExpress S.A. and Media Lario International S.A. He is also a governing trustee of a private charitable foundation in his home state of Wisconsin, and director of the non-profit organisation American Citizens Abroad.

Previous roles include: -

·     President, CEO and Chairman of Bookham (initially listed on the London Stock Exchange and subsequently listed on NASDAQ)

·     Lead independent director of NASDAQ-listed New Focus, Inc.

·     Non-executive Chairman of Photonic Materials Ltd.

·     Non-executive director of Intense Photonics Ltd.

·     Vice President and General Manager of the Source Laser business at JDSU, Inc. (previously Uniphase Corporation)

·     Vice President of Crystal Technology responsible for the materials business (Crystal Technology LLC was acquired by Gooch & Housego in 2011)

·     Director of Polytech Ventures, a Swiss-based investment fund

Dr Bordui has bachelors, masters and PhD degrees from MIT.

Mr Webster and Dr Bordui will sit on the Audit, Remuneration and Nomination Committees of the Gooch & Housego PLC Board.

There are no other disclosures required under Schedule Two (g) of the AIM rules.

Gareth Jones, Chief Executive of Gooch & Housego, commented:

"Mark Webster and Peter Bordui bring extensive business skills and in-depth knowledge of the healthcare and photonics sectors to the board. Gooch & Housego is fortunate to be able to benefit from their wisdom and experience."

For further information please contact: -

Gareth Jones/Andrew Boteler                       Gooch & Housego PLC Tim Thompson/Nicola Cronk Buchanan Patrick Robb/James Grace Investec Bank plc

Tel: [phone] Tel: [phone] Tel:  [phone]

 

END

 

 

BOABDGDDSSDBGDX